Christodoulou, P.; Kyriakou, T.-C.; Boutsikos, P.; Andreou, M.; Ji, Y.; Xu, D.; Papageorgis, P.; Christodoulou, M.-I.
Aberrant Expression and Prognostic Potential of IL-37 in Human Lung Adenocarcinoma. Biomedicines 2022, 10, 3037.
https://doi.org/10.3390/biomedicines10123037
AMA Style
Christodoulou P, Kyriakou T-C, Boutsikos P, Andreou M, Ji Y, Xu D, Papageorgis P, Christodoulou M-I.
Aberrant Expression and Prognostic Potential of IL-37 in Human Lung Adenocarcinoma. Biomedicines. 2022; 10(12):3037.
https://doi.org/10.3390/biomedicines10123037
Chicago/Turabian Style
Christodoulou, Panayiota, Theodora-Christina Kyriakou, Panagiotis Boutsikos, Maria Andreou, Yuan Ji, Damo Xu, Panagiotis Papageorgis, and Maria-Ioanna Christodoulou.
2022. "Aberrant Expression and Prognostic Potential of IL-37 in Human Lung Adenocarcinoma" Biomedicines 10, no. 12: 3037.
https://doi.org/10.3390/biomedicines10123037
APA Style
Christodoulou, P., Kyriakou, T.-C., Boutsikos, P., Andreou, M., Ji, Y., Xu, D., Papageorgis, P., & Christodoulou, M.-I.
(2022). Aberrant Expression and Prognostic Potential of IL-37 in Human Lung Adenocarcinoma. Biomedicines, 10(12), 3037.
https://doi.org/10.3390/biomedicines10123037